RxDoctor Payments Data

Marc Ernstoff

Medical Oncology · Frederick, MDNPI 1275549073

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $13,547 of the $14,472 with a category attached, or 93.6%. 3 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 49.8% of the total.

$14,472in general payments, 2019–2025

Across 14 payments — averaging $1033.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$7K
  • Alkermes, Inc.$7K
  • Clinigen, Inc.$290
$965,530in research payments, 2019–2025

Across 107 payments — averaging $9023.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Alkermes, Inc.$948K
  • E.r. Squibb & Sons, L.L.C.$17K
  • Merck$615

What the payments were for

  • Consulting fees$13,54794%
  • Travel & lodging$3122%
  • Food & beverage$6134%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
E.r. Squibb & Sons, L.L.C.9$7,207
Alkermes, Inc.3$6,975
Clinigen, Inc.2$290

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,472 in reported general payments places this provider in the 65th percentile of 180 medical oncology providers in Maryland.

See all medical oncology providers in Maryland →

Other medical oncology in Frederick

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →